Wisconsin Senate Bill SB832

Wisconsin 2025-2026 Regular Session

• Introduced: 1/15/26
• Refer: 1/15/26
• Report Pass: 2/3/26
• Engrossed: 2/11/26
• Refer: 2/18/26
• Enrolled: 2/24/26
• Chaptered: 4/6/26
• Passed: 4/6/26

Caption

An Act to repeal 450.09 (2) (b) 1. a. to d.; to renumber 450.09 (2) (b) 2. b.; to renumber and amend 450.09 (2) (b) 2. a.; to consolidate, renumber and amend 450.09 (2) (b) 1. (intro.) and 2. (intro.); to amend 450.01 (21c), 450.02 (5) and 450.09 (1) (a) of the statutes; Relating to: remote dispensing sites under the pharmacy practice law.

Impact

If enacted, SB832 would modify existing laws to allow pharmacies operating as remote dispensing sites to provide pharmaceutical services with less stringent oversight. This change is intended to improve access to medications for patients, particularly in underserved regions. The bill would consolidate various statutory requirements related to remote dispensing, allowing for more streamlined operations. This legislation reflects an effort by state lawmakers to adapt to the evolving landscape of healthcare delivery, particularly in light of recent trends toward telehealth and remote services.

Summary

Senate Bill 832 aims to amend the regulations governing pharmacies in Wisconsin, specifically addressing the operations of remote dispensing sites under the pharmacy practice law. The bill proposes significant changes to several sections of the statutes, specifically removing certain requirements for pharmacist presence at remote dispensing sites, which are pharmacies that operate under different supervision rules than traditional pharmacies. By redefining what constitutes a 'remotely supervised pharmacy', the bill seeks to facilitate more flexible pharmacy operations to better serve communities, particularly in rural areas where access to pharmacists may be limited.

Sentiment

The general sentiment surrounding SB832 appears to be cautiously optimistic among supporters, particularly pharmacists and healthcare providers, who see it as a means to enhance patient access to necessary medications. However, there are also concerns among some stakeholders regarding the adequacy of oversight in these settings, suggesting a tension between improving access and ensuring patient safety. Discussions in committee meetings indicate support for the bill but highlight a need for careful consideration of the regulations that should remain in place to safeguard public health.

Contention

Notable points of contention include the potential risks associated with reducing the requirement for pharmacist supervision in remote dispensing sites. Critics argue that while access to medication is vital, oversight is equally important to prevent medication errors and ensure safe dispensing practices. They express concerns that less regulation could lead to inadequate patient care and oversight in these remote pharmacies. Proponents of the bill counter that advancements in technology and changing patient needs necessitate a shift in how pharmacy services are delivered, advocating for a balance that maintains safety while enhancing accessibility.